| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.7312338229297874 2.9063219289343296 0.0036570498447978 0.8922090898337951 0.3401152501863224 22 Q16850,Q15125,P37268,P48449,Q15392,Q15800,Q9BWD1,Q14739 8 |
| Target of rapamycin tor signaling 0.7394168719995362 2.3443348281637624 0.0190610510841044 0.9999917144155268 0.4518664905628284 13 P62942 1 |
| Ferroptosis 0.6269191795487249 2.2911757707473543 0.0219532497091174 0.9999986239140533 0.4602612352808081 22 P09601,P37268 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.894430765076953 2.2035110912656632 0.0275587461063464 0.9999999582235258 0.5236161760205826 6 Q16850,Q14739,Q15125,Q15392 4 |
| Sphingolipid metabolism integrated pathway 0.7860603113718898 2.150209141050815 0.0315386754265523 0.9999999965483448 0.5639857252748177 8 Q16739,Q96G23,Q06136,O95470,O15270 5 |
| Sphingolipid metabolism overview 0.7860603113718898 2.150209141050815 0.0315386754265523 0.9999999965483448 0.5639857252748177 8 Q16739,Q96G23,Q06136,O95470,O15270 5 |
| Statin inhibition of cholesterol production 0.8744476814200973 2.1250534974377606 0.0335821492190004 0.9999999990443794 0.5699374432876927 6 P37268 1 |
| Metapathway biotransformation phase i and ii 0.5883338991658464 2.123090177214079 0.0337462959841396 0.9999999991381484 0.5699374432876927 24 P07099,Q16850,O15217,Q8NCH0,Q86UY6 5 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.7136317049694648 2.1007343890873686 0.0356642887752784 0.9999999997425008 0.573752666165209 12 P13674,Q96AY3,Q32P28,O15460 4 |
| Head and neck squamous cell carcinoma 0.611365188468521 2.098516525593399 0.0358595416353255 0.9999999997723292 0.573752666165209 19 P62942,P06730 2 |
| Sphingolipid metabolism in senescence 0.7289953302868106 2.035832922604913 0.0417671352733075 0.9999999999945748 0.646356276366293 10 Q16739,Q96G23,Q06136,P28482,P04062 5 |
| Sphingolipid pathway 0.7274027565912319 2.028360786120438 0.0425234392346245 0.9999999999966432 0.646356276366293 10 Q16739,Q96G23,Q06136,O95470,O15270,P04062 6 |
| Folate metabolism 0.6204025208900292 2.0162529022700504 0.043773537090034 0.9999999999984832 0.6491295256278222 17 P00374,P41440,Q8WTV0,P34896 4 |
| Cholesterol biosynthesis pathway 0.6919152891558163 1.9934729949065455 0.0462096777765714 0.9999999999996784 0.6689400973370346 12 P48449,Q16850,Q15800,P37268 4 |
| Spinal cord injury 0.5856496698221393 1.9712120811028409 0.0486996226321581 0.9999999999999344 0.6885900130314448 20 P62942,P14174,P04083,P28482 4 |
| Metabolism of spingolipids in er and golgi apparatus 0.8103551283044879 1.868736326206212 0.0616595074262447 1.0 0.6950330897348515 6 Q16739,Q06136,O95470,P15291 4 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6829865885517132 1.8496172602244771 0.0643687333121574 1.0 0.6950330897348515 11 O95140,Q9NR77 2 |
| Nanomaterial induced apoptosis 0.8261763353701398 1.8142479146966233 0.0696395664269597 1.0 0.6950330897348515 5 O95831,P49327,Q9NR28 3 |
| Regucalcin in proximal tubule epithelial kidney cells 0.7511006109668696 1.8025803941626284 0.0714541383898668 1.0 0.6950330897348515 7 P31749,P28482 2 |
| Mecp2 and associated rett syndrome 0.5483237621402418 1.7951825119787763 0.0726246258246052 1.0 0.6950330897348515 22 P31943,Q03518,P31749,Q13451,P67809,P35637 6 |
| Caloric restriction and aging 0.8213141481652884 1.7947624832232123 0.0726915505646204 1.0 0.6950330897348515 5 P43490 1 |
| Allograft rejection 0.6747688208344974 1.7777332808749975 0.0754476709251648 1.0 0.6950330897348515 10 P08183,P10321,P04439,P49327,P08670,Q9BY49,P42574 7 |
| Adipogenesis 0.5935540952335281 1.696264487029942 0.0898358027245489 1.0 0.7715614159087822 14 P14174,P43490,O75844 3 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.6568271195186146 1.690707964702136 0.0908925923779433 1.0 0.7715614159087822 10 P37268 1 |
| Nrf2 pathway 0.5363369189916505 1.6880144179392955 0.0914084612935917 1.0 0.7715614159087822 21 O15217 1 |
| Ethanol effects on histone modifications 0.6420255013391201 1.648338903268157 0.0992831457869625 1.0 0.775912986905648 11 P00374 1 |
| Cytosine methylation 0.8674392066677463 1.606321369931463 0.1082033173453247 1.0 0.7926218909151499 4 P48735 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7724382298279312 1.597168464565086 0.1102281601648145 1.0 0.7972547112253048 5 P09601 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4865569587361857 1.5858665690939964 0.1127695808641056 1.0 0.7972547112253048 31 P48449,Q16850,Q8WTV0,P37268 4 |
| Proteasome degradation 0.4548829283991994 1.5658130286402547 0.1173923952027387 1.0 0.8005445922001395 41 P28070,P25786,P10321,P20618,P28074,P49721,P28072 7 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.7507710025420747 1.5086860998936873 0.1313790193845085 1.0 0.8005445922001395 5 P31749,P42574 2 |
| Familial partial lipodystrophy fpld 0.6817778230157513 1.499186697146099 0.1338252051334745 1.0 0.8005445922001395 7 O60725 1 |
| Vitamin d metabolism 0.9299458809380632 1.4990207443344203 0.1338682505668045 1.0 0.8005445922001395 3 P38435,P04062 2 |
| Proteoglycan biosynthesis 0.7476574684995339 1.4959336321773085 0.1346709509575789 1.0 0.8005445922001395 5 Q8NCH0 1 |
| Alzheimers disease 0.4056065870060968 1.488319880655656 0.1366665544440606 1.0 0.8005445922001395 91 P28070,P25786,O95197,P12235,P28074,Q9UJX6,P42574,P60900,P20618,P49721,P28072,P0DP25,O15111,P21796,P45880,P31749,P49327,O14641,P78536,P16615,Q07866,Q00535,P28482 23 |
| Alzheimers disease and mirna effects 0.4033752265208397 1.4548028175659895 0.1457238579534703 1.0 0.8191276199620023 92 P28070,P25786,O95197,P12235,P28074,Q9UJX6,P42574,P60900,P20618,P49721,P28072,P0DP25,O15111,P21796,P45880,P31749,P49327,O14641,P78536,P16615,Q07866,Q00535,P28482 23 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6136919044675289 1.451565425423881 0.1466224781551282 1.0 0.8191276199620023 9 P31749,P06730 2 |
| Striated muscle contraction pathway 0.6667342006851589 1.4323521237711476 0.1520430728232034 1.0 0.825248266692557 7 P67936,P08670,P09493 3 |
| Immune response to tuberculosis 0.8193072888474222 1.4208573861996912 0.1553582236177182 1.0 0.825248266692557 4 O60244,Q03518 2 |
| Kennedy pathway from sphingolipids 0.8163495155025113 1.409426553678174 0.1587090768850423 1.0 0.825248266692557 4 O95470 1 |
| Mitochondrial complex iii assembly 0.5996909752909549 1.408661122772351 0.1589353958499089 1.0 0.825248266692557 10 O14949,Q9UDW1 2 |
| Kallmann syndrome 0.8138338535312506 1.3997024900082562 0.1616024278567231 1.0 0.825248266692557 4 P31749,P28482 2 |
| Vitamin b12 metabolism 0.5984442235740343 1.3765356379302494 0.1686558617346327 1.0 0.8314895723490826 9 Q8WTV0 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5541967312640418 1.3729405139015587 0.1697708403535007 1.0 0.8314895723490826 13 Q16836,P23786,O43772 3 |
| Ketogenesis and ketolysis 0.6847162994409703 1.3480109270976133 0.1776548681135208 1.0 0.8314895723490826 6 O43772 1 |
| Electron transport chain oxphos system in mitochondria 0.4077465846883524 1.347604571836285 0.1777855993509551 1.0 0.8314895723490826 55 Q7KZN9,O43676,P20674,O75964,P12235,Q9Y6M9,Q9UDW1,O75306,O75438,O95168,P00846,P14406,O75880,O14949 14 |
| Oxidation by cytochrome p450 0.6984941190131517 1.2936350974404796 0.1957914933010507 1.0 0.8650023268178098 5 O43169 1 |
| Serine metabolism 0.6305645263224715 1.2705715563587447 0.2038811112709728 1.0 0.8729557440334612 7 P00374,P34896 2 |
| Onecarbon metabolism and related pathways 0.5333871154966078 1.257925625627687 0.2084186551338218 1.0 0.8741866663997035 13 P35790,P34896 2 |
| Vitamin d receptor pathway 0.5237283719679366 1.2042736367508216 0.2284838328183573 1.0 0.8959354761459465 13 P08183,P04080,Q92783,P09493,Q5VV42,Q96KA5 6 |
| Nephrotic syndrome 0.5345083219140329 1.1783577038055282 0.2386540322197925 1.0 0.8959354761459465 12 Q14108,O75844 2 |
| Angiogenesis 0.7490143452713203 1.1492229603665578 0.250464055563931 1.0 0.9061102938041627 4 P31749,P28482 2 |
| 3q29 copy number variation syndrome 0.5269827537772447 1.1381091173514744 0.2550749214995336 1.0 0.9061102938041627 12 P31749,O94888 2 |
| Copper homeostasis 0.5451498059971518 1.1339342184603705 0.2568221422513717 1.0 0.9061102938041627 10 P78536,Q9Y6N1,P31749,P42574,O75880 5 |
| Alpha 6 beta 4 signaling pathway 0.5240054213208357 1.1221703459511594 0.2617900184581203 1.0 0.9061102938041627 12 P31749,P11047,P28482 3 |
| Vitamin a and carotenoid metabolism 0.822729777425986 1.1012216286599954 0.2708002105679092 1.0 0.9188255314002868 3 Q8WTV0 1 |
| Oxysterols derived from cholesterol 0.5597407063933798 1.101212368369971 0.2708042399159112 1.0 0.9188255314002868 8 Q15125 1 |
| Apoptosis modulation by hsp70 0.6212657657601307 1.0795284859366303 0.2803522021523481 1.0 0.9254190972959734 6 O95831,P49327,P42574 3 |
| Progeriaassociated lipodystrophy 0.5338783731582969 1.076769815290643 0.2815831134864393 1.0 0.9254190972959734 10 O60725 1 |
| Male infertility 0.4477433704392359 1.062038522705004 0.2882181972099529 1.0 0.933849919157716 19 P08183,Q15165,P34896,P41440,P49327 5 |
| 7oxoc and 7betahc pathways 0.5256024924304932 1.0347675338674067 0.300777488348241 1.0 0.9495495244908502 10 Q15125,Q9UBM7 2 |
| Cohesin complex cornelia de lange syndrome 0.4616719939279253 1.0125505107720765 0.311274908591898 1.0 0.9495495244908502 16 P30154 1 |
| Mitochondrial complex iv assembly 0.4878285315177776 1.003907452181222 0.3154232242360852 1.0 0.9495495244908502 13 P14406,Q7KZN9,Q9Y2R0,P20674 4 |
| Disruption of postsynaptic signaling by cnv 0.5346063409857165 0.9805806251360089 0.3267995926096294 1.0 0.9552603476281476 8 P28482,Q06787,Q14168 3 |
| Triacylglyceride synthesis 0.7829224293445554 0.956165896669517 0.338988426655668 1.0 0.9721932236162554 3 O15228,O00116 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5572715601448799 0.9409003223002458 0.3467559424501254 1.0 0.982584732357644 7 P31749 1 |
| Disorders of folate metabolism and transport 0.5260130727599964 0.9394014156220764 0.3475246864763976 1.0 0.982584732357644 8 P00374 1 |
| Nuclear receptors metapathway 0.3680744141611722 0.935837909683147 0.349356649609257 1.0 0.982584732357644 50 O15217,P23786,P09601,Q15067 4 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.5866034595782179 0.9332473965759848 0.3506922482263301 1.0 0.982584732357644 6 O15111,P06730 2 |
| Phosphodiesterases in neuronal function 0.7379020138262513 0.8878094948234206 0.3746432346869808 1.0 0.9946859680772242 2 O43924 1 |
| Onecarbon metabolism 0.4448633705579515 0.8730377775704139 0.3826424869442872 1.0 1.0 15 P00374,P34896 2 |
| Erk pathway in huntingtons disease 0.6727372165063132 0.8591858998297573 0.3902379613094564 1.0 1.0 4 P42858,P28482 2 |
| Cellular proteostasis 0.5688890101447857 0.8590686166793344 0.390302660579835 1.0 1.0 6 Q9UHV9,O60925 2 |
| Influence of laminopathies on wnt signaling 0.4742736746578034 0.8556572198298426 0.3921874098008358 1.0 1.0 12 O60725 1 |
| Embryonic stem cell pluripotency pathways 0.446973965525642 0.8521278356123815 0.394143144045024 1.0 1.0 14 P31749,O14641,P28482 3 |
| Pyrimidine metabolism 0.3572665308373758 0.8264754455547897 0.4085344413195306 1.0 1.0 46 Q9H773,Q9Y2S7,P17812,Q14181,Q9NR33,Q7LG56,Q9NRF8 7 |
| Complement system in neuronal development and plasticity 0.4812886096704534 0.8103990183786315 0.4177108818630402 1.0 1.0 10 P49327,P42574,Q5KU26,Q9NR28 4 |
| Nonalcoholic fatty liver disease 0.3502854105802926 0.7889486578085096 0.4301420150502988 1.0 1.0 56 O43676,P20674,P49327,Q9UDW1,O75306,P31749,O75438,O95168,Q86Y39,P14406,O14949 11 |
| Translation factors 0.3700076358578699 0.7693795572377105 0.4416680207277359 1.0 1.0 37 P06730,O75153 2 |
| Neural crest cell migration in cancer 0.4683322420042812 0.7625811048773306 0.4457132567983914 1.0 1.0 11 Q99523 1 |
| Transsulfuration and onecarbon metabolism 0.4010064005254233 0.7540569940147327 0.4508149995150736 1.0 1.0 19 P00374,P34896 2 |
| Epo receptor signaling 0.5061290733130924 0.7141394641474429 0.4751409451195871 1.0 1.0 7 P31749,P28482 2 |
| Fluoropyrimidine activity 0.4470887132679998 0.711147880967642 0.4769926017247674 1.0 1.0 12 P00374,Q92820,P04818,Q06203 4 |
| Glycerophospholipid biosynthetic pathway 0.5054247055475124 0.7110662596045983 0.4770431770110819 1.0 1.0 7 P48651,O15228,O00116,O95674 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.4117306653995913 0.7078975925593176 0.4790088548595315 1.0 1.0 16 O75844,P25054,P11802,P55209,O60725,P50402 6 |
| Vitamin dsensitive calcium signaling in depression 0.5529716668123603 0.7014240668463433 0.4830384069193001 1.0 1.0 5 Q8NB78 1 |
| Nucleotide metabolism 0.4152094360737812 0.6969491997313687 0.4858345860891924 1.0 1.0 15 P00374 1 |
| Camkk2 pathway 0.4272273848680192 0.6671048664120715 0.5047051519228365 1.0 1.0 13 O00429,O76024,P09601,Q9Y3D6,P28482 5 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.5438658908300906 0.6660604897323373 0.5053724373602078 1.0 1.0 5 P31749,P28482 2 |
| Rala downstream regulated genes 0.512177576581176 0.6271872356467508 0.530536509258547 1.0 1.0 6 P16989 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.4452091827986744 0.6169089523549552 0.5372947815844782 1.0 1.0 9 P31943,P28482,P61020 3 |
| Riboflavin and coq disorders 0.6052610310305482 0.6157435110481846 0.5380638152129515 1.0 1.0 4 Q8NI60,Q16134 2 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.4413919797837843 0.6119154175849308 0.5405937204597326 1.0 1.0 10 O60566,Q9UJX6,Q02224 3 |
| Apoptosis 0.3724682921335049 0.5334642039653327 0.5937122837854929 1.0 1.0 18 Q9NR28,Q13546,Q99590,P31749,P49327,P42574,O15111 7 |
| Photodynamic therapyinduced ap1 survival signaling 0.4243187579026286 0.5291612766881335 0.5966935765882717 1.0 1.0 10 P49327,Q16539,P42771 3 |
| Angiopoietinlike protein 8 regulatory pathway 0.3460006347145932 0.5226089928659944 0.6012463811476034 1.0 1.0 33 P46108,P31749,P41440,P06730,P49327 5 |
| Endometrial cancer 0.3877837980303247 0.5130240558152535 0.607934493524215 1.0 1.0 14 P31749,Q9UJX6,P28482 3 |
| Hedgehog signaling pathway wp47 0.629696423204092 0.4992789512181371 0.6175828814903452 1.0 1.0 2 O00422 1 |
| Type ii interferon signaling ifng 0.4288885723816825 0.4873673816667584 0.6259980046222968 1.0 1.0 8 P15260,Q03518 2 |
| Tnfalpha signaling pathway 0.3480122322198318 0.4805633933799452 0.6308268378710773 1.0 1.0 25 P62993,Q9NR28,Q13546,P31749,P28482,P42574,O15111 7 |
| Nitric oxide metabolism in cystic fibrosis 0.5645112781954916 0.4799694672134739 0.6312491039891284 1.0 1.0 4 Q99873,Q86X55,O14744 3 |
| Glycogen synthesis and degradation 0.3579200107808866 0.4759225364543913 0.6341295659577413 1.0 1.0 19 P46976,P30154,P30153,P52789,P0DP25 5 |
| Primary focal segmental glomerulosclerosis fsgs 0.357150838088476 0.4710799445944228 0.6375836463776574 1.0 1.0 19 P31749,Q14108,P11047 3 |
| Methylation pathways 0.5600657375627786 0.4658535431897883 0.6413203363567703 1.0 1.0 4 P21964 1 |
| Complement system 0.4079274616187534 0.4625775084376134 0.6436672333879541 1.0 1.0 11 P26885 1 |
| Dna mismatch repair 0.3509617580797139 0.4493325177262459 0.6531918035425677 1.0 1.0 21 Q9UQ84,Q9NR33,P41440 3 |
| Relationship between inflammation cox2 and egfr 0.4848073503227024 0.4482028966732063 0.6540067723843377 1.0 1.0 5 P31749,P28482 2 |
| Oxidative phosphorylation 0.3358054261857571 0.4431308508577415 0.6576710915709922 1.0 1.0 33 O75964,O75306,O75438,O95168,Q86Y39,P00846 6 |
| Pyrimidine metabolism and related diseases 0.4079557736181827 0.4418350094550001 0.6586086025927747 1.0 1.0 9 Q9H0P0 1 |
| Mthfr deficiency 0.4114727870342852 0.4118068370794324 0.6804810096698986 1.0 1.0 8 P35790,P21964 2 |
| Wntbetacatenin signaling pathway in leukemia 0.4527713707095913 0.401685182657565 0.6879157306964663 1.0 1.0 6 P31749,P25054 2 |
| Glycosylation and related congenital defects 0.3990305026467373 0.4015061432506581 0.6880475161225439 1.0 1.0 9 Q9Y5P6,O75340,Q13724,P15291 4 |
| Integrated cancer pathway 0.3573551690626196 0.3881490064618744 0.6979057674067233 1.0 1.0 16 P31749,P42574,P53350,O14757 4 |
| Dna damage response 0.3346386663721708 0.3879645285228209 0.6980422837725437 1.0 1.0 25 O14757,Q00535,P41440,P49327,Q7LG56 5 |
| Network map of sarscov2 signaling pathway 0.3314330264951745 0.3873500385443624 0.6984970857772139 1.0 1.0 29 Q99829,Q07021,P31749,P07858,Q9P253,P06730,Q08380,P31350,P42574 9 |
| Biomarkers for pyrimidine metabolism disorders 0.3954509186141672 0.3855498710029447 0.6998300650447762 1.0 1.0 9 Q9H0P0 1 |
| Complement and coagulation cascades 0.6031267985612769 0.373880243553198 0.7084934156267857 1.0 1.0 3 P49257 1 |
| Il6 signaling pathway 0.3787393390933758 0.3638473333454964 0.7159720147157382 1.0 1.0 12 P31749,P28482 2 |
| Mirna regulation of dna damage response 0.3272522048593235 0.3512992678910064 0.7253638441258274 1.0 1.0 26 O14757,Q00535,P41440,P49327,Q7LG56 5 |
| Pi3kakt signaling pathway 0.3059716610510352 0.3496145539324817 0.7266279869867984 1.0 1.0 46 P11047,P30154,P31749,P30153,P06730,P28482 6 |
| Wnt signaling pathway and pluripotency 0.341069868214859 0.3435170859306217 0.731209489270402 1.0 1.0 18 P30154,P30153 2 |
| Wnt signaling pathway 0.3522284509378043 0.3390033333828709 0.7346072190271928 1.0 1.0 15 P31749,O14641 2 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3712177174496999 0.3281439211781415 0.742802846576228 1.0 1.0 12 P06730 1 |
| Egfr tyrosine kinase inhibitor resistance 0.3403608514134233 0.3152385124330793 0.7525805664245275 1.0 1.0 17 P31749,P28482,P06730 3 |
| Mitochondrial complex i assembly model oxphos system 0.3209549479523324 0.3150818374840266 0.7526995182935652 1.0 1.0 30 Q8N183,O43676,Q9Y6M9,Q96CU9,Q9NPL8,O75306,O75438,O95168 8 |
| Tlr4 signaling and tolerance 0.3871073270099457 0.3111247845596847 0.7557057601752228 1.0 1.0 8 Q15629,O15111 2 |
| Chromosomal and microsatellite instability in colorectal cancer 0.324235931237308 0.2810336572083039 0.7786845849621149 1.0 1.0 21 P31749,P11233,Q9UJX6,P28482 4 |
| Nocgmppkg mediated neuroprotection 0.3788656029105065 0.2786585346016582 0.7805068870258911 1.0 1.0 8 P30536 1 |
| Nonsmall cell lung cancer 0.3369209681189626 0.2758613666439022 0.7826545478648301 1.0 1.0 16 P62993,Q13043,P31749,P42771,P28482,P42574 6 |
| Dna replication 0.314485380066197 0.2688198750041463 0.7880682980954343 1.0 1.0 30 P41440,Q9Y2S7,Q14181,Q9Y619 4 |
| Thermogenesis 0.3138260320533856 0.2671841596215007 0.7893273717487541 1.0 1.0 31 O43772 1 |
| Pancreatic adenocarcinoma pathway 0.3133772935677226 0.2569506992953647 0.7972168317399266 1.0 1.0 27 Q13177,P11233,P31749,P30086,P42771,P28482,O15111 7 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3476996430992594 0.2555040908449593 0.7983337844066973 1.0 1.0 13 Q13546,P31749,P28482,P42574,O15111 5 |
| Apoptosis modulation and signaling 0.3199817563172215 0.2461530771701465 0.8055637371196465 1.0 1.0 19 Q9NR28,Q13546,O95831,P42771,P49327,P42574 6 |
| Netrinunc5b signaling pathway 0.3344419847481036 0.2459312036474161 0.8057354884677155 1.0 1.0 15 P30154,P28482,P31749 3 |
| Bdnftrkb signaling 0.3552835875203157 0.2209562567070841 0.8251264932371432 1.0 1.0 10 P31749,P28482 2 |
| Reninangiotensinaldosterone system raas 0.5376766795661361 0.2208733901321831 0.8251910173341153 1.0 1.0 3 P0DP25 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.5166816952209259 0.2064183282553058 0.8364641552268575 1.0 1.0 2 Q15758 1 |
| Bile acids synthesis and enterohepatic circulation 0.4617049604984938 0.201540716741364 0.8402757951810136 1.0 1.0 4 P51114 1 |
| Endothelin pathways 0.3581495524464032 0.2012589903369698 0.840496067390309 1.0 1.0 8 P28482,P42892 2 |
| Robo4 and vegf signaling pathways crosstalk 0.5124737000300569 0.1985941866662957 0.842580201404939 1.0 1.0 2 P63000 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3124890799227736 0.1830447566199269 0.8547629011231681 1.0 1.0 18 P28482,Q14739,P62993,P50402 4 |
| Melanoma 0.3212763221909093 0.1805905751088914 0.8566889542207101 1.0 1.0 15 P62993,P31749,P42771,P28482,P0DP25 5 |
| Familial hyperlipidemia type 4 0.4507687860703409 0.1789242857377857 0.8579971532300972 1.0 1.0 4 P49327 1 |
| Il7 signaling pathway 0.3674537059751015 0.1776621021834848 0.8589883497618325 1.0 1.0 7 P31749 1 |
| Neovascularisation processes 0.4418868713407178 0.1616796405950744 0.8715581380333548 1.0 1.0 4 P31749 1 |
| Integrinmediated cell adhesion 0.3003803946382917 0.1499575372584992 0.8807981167139085 1.0 1.0 23 P46108,P31749,P28482 3 |
| Il18 signaling pathway 0.2822313118024266 0.1358518060746926 0.8919384353318955 1.0 1.0 62 Q8TCT8,Q16836,Q9UMR5,Q92733,P09601,P49327,Q9HC07,P35613 8 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.3641323846469898 0.1305826682642349 0.8961054540347688 1.0 1.0 6 P25054,O14641 2 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3177818829708944 0.1225369745133797 0.9024737651900174 1.0 1.0 13 P31749 1 |
| Il9 signaling pathway 0.360273348817748 0.1212623023448678 0.9034832779943738 1.0 1.0 6 P28482 1 |
| Monoamine transport 0.4132330827067711 0.1130219290844476 0.910013169711056 1.0 1.0 4 O15127,Q16539,P49815 3 |
| Kisspeptinkisspeptin receptor system in the ovary 0.3432216366657066 0.1077717043041349 0.914176788824418 1.0 1.0 7 P31749 1 |
| Follicle stimulating hormone fsh signaling pathway 0.324050563566161 0.1036071513167117 0.9174811122802342 1.0 1.0 10 P31749 1 |
| Eicosanoid synthesis 0.4535801395577375 0.0935142995052407 0.9254949901119168 1.0 1.0 3 P09960 1 |
| Interferon type i signaling pathways 0.2975963670408904 0.0925068687423703 0.9262953341563772 1.0 1.0 17 P06730 1 |
| Degradation pathway of sphingolipids including diseases 0.3466781000099491 0.0903410357073783 0.9280162116735592 1.0 1.0 6 P17900 1 |
| Tcell receptor tcr signaling pathway 0.2900278593752758 0.0874042298953151 0.9303502072781182 1.0 1.0 22 P46108,P28482,P31749,P49327,P08670 5 |
| Hepatitis c and hepatocellular carcinoma 0.3084121901854996 0.0846901322348677 0.9325077411182434 1.0 1.0 13 P31749,P62993,P42574,Q16539 4 |
| Mapk cascade 0.3342447959150786 0.0844675353707097 0.9326847135923828 1.0 1.0 7 P28482 1 |
| Sulfation biotransformation reaction 0.4107035478051771 0.0576987224443129 0.9539886113443934 1.0 1.0 3 P11413,O43252 2 |
| Preimplantation embryo 0.310635572419527 0.051444837679219 0.9589710567512428 1.0 1.0 8 Q99729 1 |
| Hepatocyte growth factor receptor signaling 0.3027086761173562 0.0451176358716277 0.9640135443433464 1.0 1.0 12 P46108,P28482 2 |
| Praderwilli and angelman syndrome 0.3108444495968208 0.0307242426499725 0.9754894574478088 1.0 1.0 7 Q7L576,P42771 2 |
| Ras and bradykinin pathways in covid19 0.3102243325113497 0.0277896650292849 0.977829908892655 1.0 1.0 5 P28482 1 |
| Nucleotide excision repair 0.2763917211680479 0.0229941939706381 0.9816549042664158 1.0 1.0 25 Q9NR33,P54725,P41440 3 |
| Tp53 network 0.2681900180396947 0.0227470680682857 0.9818520306462032 1.0 1.0 3 Q07812,P42771 2 |
| Familial hyperlipidemia type 5 0.254359591100428 0.0223755096401719 0.982148415936329 1.0 1.0 3 Q9UBV2,Q07954 2 |
| Familial hyperlipidemia type 1 0.254359591100428 0.0223755096401719 0.982148415936329 1.0 1.0 3 Q9UBV2,Q07954 2 |
| Nanoparticlemediated activation of receptor signaling 0.3064855085990501 0.0218585902083155 0.9825607571020564 1.0 1.0 7 P28482 1 |
| Interleukin1 il1 structural pathway 0.2916935810889428 0.0088240514797542 0.9929595169272531 1.0 1.0 12 P28482,O15111,P06730 3 |
| Bladder cancer 0.2989541775108546 0.0060999289821753 0.9951329910260116 1.0 1.0 6 P28482,P42771 2 |
|
|
